TaiMed Biologics Inc. announced change of the Company's CEO. In consideration of his approaching the retirement age, current chairman and CEO James Chang has decided to step down from the CEO post and will be succeeded by Jimmy Chang, Chief Operating Officer of TaiMed. The change has received full approval from the board of directors and will take effect on June 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
89.4 TWD | -0.11% | -0.11% | +9.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.02% | 749M | |
+16.44% | 122B | |
+19.55% | 115B | |
+21.22% | 26.64B | |
-23.71% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.27% | 15.49B | |
+63.88% | 14.83B | |
+2.12% | 13.67B |
- Stock Market
- Equities
- 4147 Stock
- News TaiMed Biologics Inc.
- TaiMed Biologics Inc. Announces Change of CEO